BIOTRONIK Announces First Enrollment in CRT-Next Study

BIOTRONIKBIOTRONIK has announced first enrollment in a multicenter study that aims to demonstrate that a two-lead cardiac resynchronization therapy (CRT) system with atrial sensing is at least as effective as a conventional three-lead system. BIOTRONIK's CRT-DX technology provides therapy through two ventricular leads and features a floating dipole for complete atrial diagnostics without an additional lead. The study is sponsored by the Italian patient organization 'Associazione Portatori Dispositivi Impiantabili Cardiaci' (Association of Implantable Cardiac Devices Patients, APDIC).

"We are proud to be a volunteer association that has become a promoter of CRT," said Dr. Armando Luisi, president of APDIC. "Regardless of the outcome of the CRT-Next study, the findings will be useful to improve the quality of life of patients who need CRT devices."

As CRT-D patients are exposed to a higher risk of complication compared to other cardiac implantable electronic device (CIED) patients, managing risk is important. The CRT-DX system offers AV-synchronous CRT pacing without a separate atrial lead for patients not requiring atrial pacing. In reducing system complexity by eliminating the atrial lead, the CRT-DX system is designed to lower the risk of lead-related adverse events.

"This study was initiated to respond to a specific patient need: to benefit the most from the therapies available with the least risk of adverse events," reported Dr. Mauro Biffi, chief investigator of the Policlinico Sant'Orsola Malpighi, Bologna, Italy, and coordinator of the study, after implanting the novel CRT-DX system in the first patient in the CRT-Next study. "Each patient receives everything that is needed for clinical improvement while avoiding lead redundancy which can cause unfavorable problems. In Italy, this is the first clinical study in the field of implantable devices that is promoted by a non-profit association working in the interest of patients. The study reflects the solid cooperation that can be established between healthcare professionals when the objectives are clear and aim at improving care and quality of life."

The CRT-Next study is being conducted in twenty Italian centers. It enrolls 640 patients with optimized therapy for heart failure with an indication for the implantation of a CRT device.

"The technology impact for patients with heart failure and indication for a CRT-DX device can be significantly improved with the CRT-NEXT study," said Dr. Gabriele Zanotto, Head of the Unit of Pacing and Electrophysiology at the Mater Salutis Hospital in Legnago, Italy, who recently enrolled his first patient in the study. "The possibility to demonstrate that we can reduce complications in these patients is the essence of this study. We have full confidence in its scientific impact."

About BIOTRONIK

BIOTRONIK is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.

Most Popular Now

IBM Watson Health Recognizes Top-Perform…

IBM (NYSE: IBM) Watson Health® announced its 2020 Fortune/IBM Watson Health 100 Top Hospitals list and 15 Top Health Systems award winners, naming the top-performing hospitals and health systems in...

Chatbots can Ease Medical Providers' Bur…

COVID-19 has placed tremendous pressure on health care systems, not only for critical care but also from an anxious public looking for answers. Research from the Indiana University Kelley School...

Abbott Receives FDA Approval for New Hea…

Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The...

The New Tattoo: Drawing Electronics on S…

One day, people could monitor their own health conditions by simply picking up a pencil and drawing a bioelectronic device on their skin. In a new study, University of Missouri...

Towards an AI Diagnosis Like the Doctor…

Artificial intelligence (AI) is an important innovation in diagnostics, because it can quickly learn to recognize abnormalities that a doctor would also label as a disease. But the way that...

SARS-CoV-2 Antibody Test from Siemens He…

Public Health England, in partnership with the University of Oxford, recently conducted a head-to-head evaluation of four commercial immunoassay tests available in the UK and used for the detection of...

Researchers Develop Software to Find Dru…

Washington State University researchers have developed an easy-to-use software program to identify drug-resistant genes in bacteria. The program could make it easier to identify the deadly antimicrobial resistant bacteria that...

Philips Introduces First-of-a-Kind Mobil…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it introduced first-of-its-kind mobile Intensive Care Units (ICUs) in India. Designed to meet the critical-care requirements...

Proposed Framework for Integrating Chatb…

While the technology for developing artificial intelligence-powered chatbots has existed for some time, a new viewpoint piece in JAMA lays out the clinical, ethical, and legal aspects that must be...

Clinical-Grade Wearables Offer Continuou…

Although it might be tempting to rely on your fitness tracker to catch early signs of COVID-19, Northwestern University researchers caution that consumer wearables are not sophisticated enough to monitor...

World's Smallest Imaging Device has Hear…

A team of researchers led by the University of Adelaide and University of Stuttgart has used 3D micro-printing to develop the world's smallest, flexible scope for looking inside blood vessels...

Optimizing Neural Networks on a Brain-In…

Many computational properties are maximized when the dynamics of a network are at a "critical point", a state where systems can quickly change their overall characteristics in fundamental ways, transitioning...